Covered recipient · General Payments record
DEBRA S WEISSMAN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2021
$701.27
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $399.08 | 19 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $112.47 | 6 |
| PFIZER INC. | $81.35 | 4 |
| UCB, Inc. | $71.49 | 3 |
| Janssen Biotech, Inc. | $47.70 | 2 |
| GENZYME CORPORATION | $46.75 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.02 | 1 |
| Amgen Inc. | $15.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.30 | 02/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825266799 | CMS |
| GENZYME CORPORATION | $21.90 | 01/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 843689499 | CMS |
| GENZYME CORPORATION | $24.85 | 07/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 843689529 | CMS |
| Janssen Biotech, Inc. | $21.48 | 06/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788428999 | CMS |
| Janssen Biotech, Inc. | $26.22 | 06/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788429003 | CMS |
| Lilly USA, LLC | $20.94 | 02/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819062547 | CMS |
| Lilly USA, LLC | $18.24 | 03/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819053251 | CMS |
| Lilly USA, LLC | $21.78 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818915452 | CMS |
| Lilly USA, LLC | $23.14 | 06/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819060906 | CMS |
| Lilly USA, LLC | $8.84 | 06/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819053255 | CMS |
| Lilly USA, LLC | $19.53 | 07/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819062551 | CMS |
| PFIZER INC. | $18.55 | 01/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832926769 | CMS |
| PFIZER INC. | $23.55 | 04/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832936689 | CMS |
| PFIZER INC. | $21.23 | 06/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832912945 | CMS |
| PFIZER INC. | $18.02 | 10/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833238755 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.02 | 02/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 851876303 | CMS |
| UCB, Inc. | $25.68 | 01/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 807294181 | CMS |
| UCB, Inc. | $23.16 | 03/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 807434763 | CMS |
| UCB, Inc. | $22.65 | 05/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 807359225 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.